Ukraine Recap: CIA Chief Called Russia After Mutiny, WSJ Says
CIA Director William Burns called his Russian counterpart to say the US had no involvement in the failed
2023-07-01 15:59
Sunak Shows Frustration as Torrid June Has UK Cabinet on Edge
In a Downing Street office last week, under the glare of chandeliers and a big television screen, a
2023-07-01 12:46
Britain Faces a Giant Water Bill, And Nobody Wants to Pay It
One fifth of all water supplies lost to leaks. Over 800 sewage spills on average every day in
2023-07-01 12:45
China Plans to Name Pan Gongsheng as New PBOC Governor: WSJ
China plans to appoint Pan Gongsheng as the central bank’s new governor, the Wall Street Journal reported, citing
2023-07-01 11:56
Russia’s Scrapheap-Worthy Fleet of Oil Tankers Gets an Infusion of Newer Ships
An armada of oil tankers ferrying sanctioned oil around the globe is starting to get younger, bucking a
2023-07-01 10:16
Uruguay Budget Bill Sees Growth Slowing to 1.3% in 2023
A deep drought and global slowdown will probably slash Uruguay’s growth to 1.3% this year followed by an
2023-07-01 09:57
China Stock Investors See Humble 2023 Returns on Growth Fears
Chinese stocks are expected to see modest gains in the second half as investors grapple with just how
2023-07-01 08:55
UK Business Confidence Slumps After Inflation Shock, IoD Says
UK business confidence suffered a sudden collapse in June as fears mounted of a renewed push by the
2023-07-01 07:27
Fidelity Leads Flurry of Bitcoin ETF Refilings to Answer SEC
In a flurry of Friday afternoon activity, Fidelity Investments, Invesco, VanEck and WisdomTree filed a fresh set of
2023-07-01 05:55
US Bank Stocks Post First Monthly Gain Since Regional Tumult
Bank stocks notched their first monthly gain since before the collapse of Silicon Valley Bank in March after
2023-07-01 05:27
Stock Market Rally That Shocked Everyone Is Finally Broadening Beyond Tech
The big knock on the 2023 stock rally is that it rests on half-a-dozen companies thriving on hype.
2023-07-01 04:46
Biotech Cyteir’s Drug Flop Turns Into Boon for Investors on Cash Return
A little-known biotech company, Cyteir Therapeutics Inc., notched its best day ever — on the back of plans
2023-07-01 04:45